About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly-owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune/Roche) having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.
|
|
|
51-200 employees
View all Array BioPharma employees
|
|
Biotechnology
|
|
13034495376
|
|
Boulder, Colorado
|
|
1998
|
Array BioPharma Alternatives
Frequently Asked Questions about Array BioPharma
The decision makers in Array BioPharma are Burgess, Dave Mitchell, David Snitman, etc. Click to Find Array BioPharma decision makers emails.
Array BioPharma Staff Directory
Search Array BioPharma Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
